COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,002 Articles (22,627 medRxiv, 8,375 bioRxiv)

Most recent first Previous |  Page 815: Articles 8141-8150  | Next

Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection
Oh, C.-k., Nakamura, T., Beutler, N., Zhang, X., Pina-Crespo, J., Talantova, M., Ghatak, S., Trudler, D., Carnevale, L. N., McKercher, S. R., Bakowski, M. A., Diedrich, J. K., Roberts, A. J., Woods, A. K., Chi, V., Gupta, A. K., Rosenfeld, M. A., Kearns, F. L., Casalino, L., Shaabani, N., Liu, H., Wilson, I. A., Amaro, R. E., Burton, D. R., Yates, J. R., Becker, C., Rogers, T. F., Chatterjee, A. K., Lipton, S. A.
10.1101/2022.04.05.487060 — Posted: 2022-04-05
Screening of SARS-CoV-2 Antivirals Through a Cell-Based RNA-Dependent RNA Polymerase (RdRp) Reporter Assay
Uppal, T., Tuffo, K., Khaiboullina, S., Reganti, S., PANDORI, M. C., Verma, S. C.
10.1101/2022.04.04.486994 — Posted: 2022-04-05
Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff
Gallichotte, E. N., Nehring, M., Stromberg, S., Young, M. C., Snell, A., Daniels, J. B., Pabilonia, K. L., Vandewoude, S., Ehrhart, N., Ebel, G. D.
10.1101/2022.04.04.487083 — Posted: 2022-04-05
Immunopharmacological evaluation of adjuvant efficacy of Monophosphoryl lipid-A and CpG ODN with SARS-CoV-2 RBD antigen
Sambyal, S., Sravanthi, V., Khatri, R., Siddiqui, G., Ahmed, S., Samal, S., Sampath Kumar, H. M.
10.1101/2022.04.04.486920 — Posted: 2022-04-05
Linking private health sector to public COVID-19 response in Kisumu, Kenya: Lessons Learnt
Omollo, M., Odero, I. A., Barsosio, H. C., Karuki, S., Kuile, F. T., Okello, S. O., Oyoo, K., K'Oloo, A. K., Otieno, K., Duijn, S. V., Houben, N., Milimo, E., Aroka, R., Onsongo, S. N., Rinke de Wit, T. F.
10.1101/2022.03.29.22271489 — Posted: 2022-04-05
Effectiveness of a nation-wide COVID-19 vaccination program in Mexico
Bello-Chavolla, O. Y., Antonio-Villa, N. E., Valdes-Ferrer, S. I., Fermin-Martinez, C. A., Fernandez-Chirino, L., Ramirez-Garcia, D., Mancilla-Galindo, J., Kammar-Garcia, A., Avila-Funes, J. A., Zuniga-Gil, C. H., Garcia-Grimshaw, M., Ceballos-Liceaga, S. E., Carbajal-Sandoval, G., Montes-Gonzalez, J. A., Zaragoza-Jimenez, C. A., Garcia-Rodriguez, G., Cortes-Alcala, R., Reyes-Teran, G., Lopez-Gatell, H., Gutierrez-Robledo, L. M.
10.1101/2022.04.04.22273330 — Posted: 2022-04-05
A comparative analysis of serial measurements of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and C-reactive protein in patients with moderate COVID-19: a single center study from India
Kakar, A., Rani, P., Batra, T., Hasan, R., Choudhury, S.
10.1101/2022.03.30.22273026 — Posted: 2022-04-05
SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial
Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., te Boekhorst, P. A., Swaneveld, F., Novotny, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J., Heijmans, J.
10.1101/2022.04.04.22273314 — Posted: 2022-04-05
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients
Aggarwal, N., Beatty, L., Bennett, T. D., Carlson, N., Davis, C., Kwan, B., Mayer, D., Ong, T., Russell, S., Steele, J., Wogu, A., Wynia, M., Zane, R., Ginde, A. A.
10.1101/2022.04.03.22273360 — Posted: 2022-04-05
Surface detection of SARS-CoV-2 by lateral flow LAMP
Acker, I. D., Ware, M. J., Bracht, J. R.
10.1101/2022.04.04.487067 — Posted: 2022-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).